Immunocompromised Host

Displaying 1 - 2 of 2CSV
Theodore, D. A., Henneman, A. D., Loo, A., Shields, R. K., Eschenauer, G., Sobieszczyk, M. E., & Kubin, C. J. (2024). Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia. Journal of Antimicrobial Chemotherapy, 79(8), 1877–1884. https://doi.org/10.1093/jac/dkae175
Publication Date